Publications
-
Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis.
Swann AC,
Lafer B, Perugi G, Frye MA, Bauer M, Bahk WM, Scott J, Ha K, Suppes T.
Am J Psychiatry.
2013;
170
(1):
31-42
-
Characteristics of responders and non-responders to risperidone monotherapy or placebo in co-occurring bipolar disorder and anxiety disorder.
Seo JS,
Jamieson K, Cosgrove V, Gwizdowski IS, Yang H, Sheehan DV, McElroy SL, Suppes T.
Eur Psychiatry.
2013;
28
(3):
190-6
-
Comparison of objective and subjective assessments of sleep time in subjects with bipolar disorder.
Gonzalez R,
Tamminga C, Tohen M, Suppes T.
J Affect Disord.
2013
-
First controlled treatment trial of bipolar II hypomania with mixed symptoms: Quetiapine versus placebo.
Suppes T,
Ketter TA, Gwizdowski IS, Dennehy EB, Hill SJ, Fischer EG, Snow DE, Gonzalez R, Sureddi S, Shivakumar G, Cosgrove VE.
J Affect Disord.
2013
-
Multivariate analysis of bipolar mania: retrospectively assessed structure of bipolar I manic and mixed episodes in randomized clinical trial participants.
Swann AC,
Suppes T, Ostacher MJ, Eudicone JM, McQuade R, Forbes A, Carlson BX.
J Affect Disord.
2013;
144
(1-2):
59-64
-
Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient.
Sheehan DV,
Harnett-Sheehan K, Hidalgo RB, Janavs J, McElroy SL, Amado D, Suppes T.
J Affect Disord.
2013;
145
(1):
83-94
-
Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder.
Post RM,
Altshuler LL, Leverich GS, Frye MA, Suppes T, McElroy SL, Keck PE, Nolen WA, Kupka RW, Grunze H, Rowe M.
J Affect Disord.
2013;
147
(1-3):
288-94
-
Co-occurrence of serious or undiagnosed medical conditions with bipolar disorder preventing clinical trial randomization: a case series.
Feldman NS,
Gwizdowski IS, Fischer EG, Yang H, Suppes T.
J Clin Psychiatry.
2012;
73
(6):
874-7
-
Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder.
Vieta E,
Suppes T, Ekholm B, Udd M, Gustafsson U.
J Affect Disord.
2012;
142
(1-3):
36-44
-
Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients.
Post RM,
Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Nolen WA, Rowe M, Kupka RW, Grunze H, Goodwin FK.
J Clin Psychiatry.
2012;
73
(7):
924-30
-
Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder.
Kupfer DJ,
Angst J, Berk M, Dickerson F, Frangou S, Frank E, Goldstein BI, Harvey A, Laghrissi-Thode F, Leboyer M, Ostacher MJ, Sibille E, Strakowski SM, Suppes T, Tohen M, Yolken RH, Young LT, Zarate CA.
Ann N Y Acad Sci.
2011:
1242
1-25
-
Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany.
Post RM,
Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Nolen WA, Kupka R, Grunze H, Walden J, Rowe M.
Int Clin Psychopharmacol.
2011;
26
(2):
96-106
-
Prevalence and correlates of eating disorders in 875 patients with bipolar disorder.
McElroy SL,
Frye MA, Hellemann G, Altshuler L, Leverich GS, Suppes T, Keck PE, Nolen WA, Kupka R, Post RM.
J Affect Disord.
2011;
128
(3):
191-8
-
Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.
Post RM,
Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Leverich GS, Luckenbaugh DA, Rowe M, Pizzarello S, Kupka RW, Grunze H, Nolen WA.
J Clin Psychiatry.
2010;
71
(9):
1176-86; quiz 1252-3
-
Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood.
Post RM,
Leverich GS, Kupka RW, Keck PE, McElroy SL, Altshuler LL, Frye MA, Luckenbaugh DA, Rowe M, Grunze H, Suppes T, Nolen WA.
J Clin Psychiatry.
2010;
71
(7):
864-72
-
Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression.
Suppes T,
Datto C, Minkwitz M, Nordenhem A, Walker C, Darko D.
J Affect Disord.
2010;
121
(1-2):
106-15
-
Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network.
Altshuler LL,
Kupka RW, Hellemann G, Frye MA, Sugar CA, McElroy SL, Nolen WA, Grunze H, Leverich GS, Keck PE, Zermeno M, Post RM, Suppes T.
Am J Psychiatry.
2010;
167
(6):
708-15
-
Genetics and intermediate phenotypes of the schizophrenia--bipolar disorder boundary.
Ivleva EI,
Morris DW, Moates AF, Suppes T, Thaker GK, Tamminga CA.
Neurosci Biobehav Rev.
2010;
34
(6):
897-921
-
Is there a role for antidepressants in the treatment of bipolar II depression?
Suppes T,
Am J Psychiatry.
2010;
167
(7):
738-40
-
The quick inventory of depressive symptomatology (clinician and self-report versions) in patients with bipolar disorder.
Bernstein IH,
Rush AJ, Suppes T, Kyotoku Y, Warden D.
CNS Spectr.
2010;
15
(6):
367-73
-
A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder.
Bernstein IH,
Rush AJ, Suppes T, Trivedi MH, Woo A, Kyutoku Y, Crismon ML, Dennehy E, Carmody TJ.
Int J Methods Psychiatr Res.
2009;
18
(2):
138-46
-
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
Frye MA,
Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE, Nolen WA, Kupka R, Leverich GS, Grunze H, Mintz J, Post RM, Suppes T.
Am J Psychiatry.
2009;
166
(2):
164-72
-
Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies.
Frye MA,
Yatham L, Ketter TA, Goldberg J, Suppes T, Calabrese JR, Bowden CL, Bourne E, Bahn RS, Adams B.
Acta Psychiatr Scand.
2009;
120
(1):
10-3
-
Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
Altshuler LL,
Post RM, Hellemann G, Leverich GS, Nolen WA, Frye MA, Keck PE, Kupka RW, Grunze H, McElroy SL, Sugar CA, Suppes T.
J Clin Psychiatry.
2009;
70
(4):
450-7
-
Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
Suppes T,
Vieta E, Liu S, Brecher M, Paulsson B.
Am J Psychiatry.
2009;
166
(4):
476-88
-
Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
Goldberg JF,
Calabrese JR, Saville BR, Frye MA, Ketter TA, Suppes T, Post RM, Goodwin FK.
J Clin Psychiatry.
2009;
70
(9):
1273-80
-
Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV,
McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
J Affect Disord.
2009;
115
(3):
376-85
-
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.
Tohen M,
Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M.
Bipolar Disord.
2009;
11
(5):
453-73
-
The safety, acceptability, and effectiveness of acupuncture as an adjunctive treatment for acute symptoms in bipolar disorder.
Dennehy EB,
Schnyer R, Bernstein IH, Gonzalez R, Shivakumar G, Kelly DI, Snow DE, Sureddi S, Suppes T.
J Clin Psychiatry.
2009;
70
(6):
897-905
-
A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder.
Marangell LB,
Suppes T, Zboyan HA, Prashad SJ, Fischer G, Snow D, Sureddi S, Allen JC.
J Clin Psychiatry.
2008;
69
(2):
183-9
-
A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression.
Suppes T,
Marangell LB, Bernstein IH, Kelly DI, Fischer EG, Zboyan HA, Snow DE, Martinez M, Al Jurdi R, Shivakumar G, Sureddi S, Gonzalez R.
J Affect Disord.
2008;
111
(2-3):
334-43
-
An investigation of water lithium concentrations and rates of violent acts in 11 Texas counties: can an association be easily shown?
Gonzalez R,
Bernstein I, Suppes T.
J Clin Psychiatry.
2008;
69
(2):
325-6
-
Are bipolar mood symptoms affected by the phase of the menstrual cycle?
Shivakumar G,
Bernstein IH, Suppes T, Keck PE, McElroy SL, Altshuler LL, Frye MA, Nolen WA, Kupka RW, Grunze H, Leverich GS, Mintz J, Post RM.
J Womens Health (Larchmt).
2008;
17
(3):
473-8
-
Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists.
Bauer M,
Lecrubier Y, Suppes T.
Eur Psychiatry.
2008;
23
(3):
169-77
-
Bipolar II disorder: arguments for and against a distinct diagnostic entity.
Vieta E,
Suppes T.
Bipolar Disord.
2008;
10
(1 Pt 2):
163-78
-
Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.
Suppes T,
Eudicone J, McQuade R, Pikalov A, Carlson B.
J Affect Disord.
2008;
107
(1-3):
145-54
-
Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E,
Suppes T, Eggens I, Persson I, Paulsson B, Brecher M.
J Affect Disord.
2008;
109
(3):
251-63
-
Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies.
Weisler RH,
Calabrese JR, Thase ME, Arvekvist R, Stening G, Paulsson B, Suppes T.
J Clin Psychiatry.
2008;
69
(5):
769-82
-
Glucose testing in patients receiving antipsychotic pharmacotherapy - author reply.
Suppes T,
Psychopharmacol Bull.
2008;
41
(2):
7-8
-
Incidence of childhood-onset bipolar illness in the USA and Europe.
Post RM,
Luckenbaugh DA, Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Nolen WA, Kupka R, Grunze H, Walden J.
Br J Psychiatry.
2008;
192
(2):
150-1
-
Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.
Suppes T,
Hirschfeld RM, Vieta E, Raines S, Paulsson B.
World J Biol Psychiatry.
2008;
9
(3):
198-211
-
Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder.
Goldberg JF,
Bowden CL, Calabrese JR, Ketter TA, Dann RS, Frye MA, Suppes T, Post RM.
Biol Psychiatry.
2008;
63
(1):
125-30
-
A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
McElroy SL,
Frye MA, Altshuler LL, Suppes T, Hellemann G, Black D, Mintz J, Kupka R, Nolen W, Leverich GS, Denicoff KD, Post RM, Keck PE.
Bipolar Disord.
2007;
9
(4):
426-34
-
A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.
Frye MA,
Grunze H, Suppes T, McElroy SL, Keck PE, Walden J, Leverich GS, Altshuler LL, Nakelsky S, Hwang S, Mintz J, Post RM.
Am J Psychiatry.
2007;
164
(8):
1242-9
-
Alcoholism and anxiety in bipolar illness: differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism.
Levander E,
Frye MA, McElroy S, Suppes T, Grunze H, Nolen WA, Kupka R, Keck PE, Leverich GS, Altshuler LL, Hwang S, Mintz J, Post RM.
J Affect Disord.
2007;
101
(1-3):
211-7
-
Awareness of metabolic concerns and perceived impact of pharmacotherapy in patients with bipolar disorder: a survey of 500 US psychiatrists.
Suppes T,
McElroy SL, Hirschfeld R.
Psychopharmacol Bull.
2007;
40
(2):
22-37; quiz 38-40
-
Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
Byerly M,
Suppes T, Tran QV, Baker RA.
J Clin Psychopharmacol.
2007;
27
(6):
639-61
-
Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
Suppes T,
Kelly DI, Hynan LS, Snow DE, Sureddi S, Foster B, Curley E.
Aust N Z J Psychiatry.
2007;
41
(5):
397-402
-
Dimensions and the psychosis phenotype.
Allardyce J,
Suppes T, Van Os J.
Int J Methods Psychiatr Res.
2007:
16 Suppl 1
S34-40
-
Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
McElroy SL,
Suppes T, Frye MA, Altshuler LL, Stanford K, Martens B, Leverich GS, Post RM, Keck PE.
J Affect Disord.
2007;
101
(1-3):
275-81
-
Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network.
Suppes T,
Kelly DI, Keck PE, McElroy SL, Altshuler LL, Mintz J, Frye MA, Nolen WA, Luckenbaugh DA, Post RM, Leverich GS, Kupka RW, Grunze H.
Int Clin Psychopharmacol.
2007;
22
(6):
376-81
-
The poor prognosis of childhood-onset bipolar disorder.
Leverich GS,
Post RM, Keck PE, Altshuler LL, Frye MA, Kupka RW, Nolen WA, Suppes T, McElroy SL, Grunze H, Denicoff K, Moravec MK, Luckenbaugh D.
J Pediatr.
2007;
150
(5):
485-90
-
Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.
Kupka RW,
Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, Frye MA, Keck PE, McElroy SL, Grunze H, Post RM.
Bipolar Disord.
2007;
9
(5):
531-5
-
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study.
Nolen WA,
Kupka RW, Hellemann G, Frye MA, Altshuler LL, Leverich GS, Suppes T, Keck PE, McElroy S, Grunze H, Mintz J, Post RM.
Acta Psychiatr Scand.
2007;
115
(5):
360-5
-
Omega-3 fatty acids in bipolar disorder: clinical and research considerations.
Marangell LB,
Suppes T, Ketter TA, Dennehy EB, Zboyan H, Kertz B, Nierenberg A, Calabrese J, Wisniewski SR, Sachs G.
Prostaglandins Leukot Essent Fatty Acids.
2006 Oct-Nov;
75
(4-5):
315-21
-
An empirical analysis of cost outcomes of the Texas Medication Algorithm Project.
Kashner TM,
Rush AJ, Crismon ML, Toprac M, Carmody TJ, Miller AL, Trivedi MH, Wicker A, Suppes T.
Psychiatr Serv.
2006;
57
(5):
648-59
-
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.
Keck PE,
Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM.
Biol Psychiatry.
2006;
60
(9):
1020-2
-
Implementation of the Texas Medication Algorithm Project patient and family education program.
Toprac MG,
Dennehy EB, Carmody TJ, Crismon ML, Miller AL, Trivedi MH, Suppes T, Rush AJ.
J Clin Psychiatry.
2006;
67
(9):
1362-72
-
Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials.
Frye MA,
Yatham LN, Calabrese JR, Bowden CL, Ketter TA, Suppes T, Adams BE, Thompson TR.
J Clin Psychiatry.
2006;
67
(11):
1721-8
-
Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report.
Joffe H,
Cohen LS, Suppes T, Hwang CH, Molay F, Adams JM, Sachs GS, Hall JE.
Biol Psychiatry.
2006;
60
(12):
1378-81
-
Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.
Altshuler LL,
Suppes T, Black DO, Nolen WA, Leverich G, Keck PE, Frye MA, Kupka R, McElroy SL, Grunze H, Kitchen CM, Post R.
Am J Psychiatry.
2006;
163
(2):
313-5
-
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
Post RM,
Altshuler LL, Leverich GS, Frye MA, Nolen WA, Kupka RW, Suppes T, McElroy S, Keck PE, Denicoff KD, Grunze H, Walden J, Kitchen CM, Mintz J.
Br J Psychiatry.
2006:
189
124-31
-
New findings from the Bipolar Collaborative Network: clinical implications for therapeutics.
Post RM,
Altshuler LL, Frye MA, Suppes T, McElroy S, Keck PE, Leverich GS, Kupka R, Nolen WA, Grunze H.
Curr Psychiatry Rep.
2006;
8
(6):
489-97
-
Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.
Calabrese JR,
Goldberg JF, Ketter TA, Suppes T, Frye M, White R, DeVeaugh-Geiss A, Thompson TR.
Biol Psychiatry.
2006;
59
(11):
1061-4
-
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Leverich GS,
Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM.
Am J Psychiatry.
2006;
163
(2):
232-9
-
Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study.
Altshuler LL,
Post RM, Black DO, Keck PE, Nolen WA, Frye MA, Suppes T, Grunze H, Kupka RW, Leverich GS, McElroy SL, Walden J, Mintz J.
J Clin Psychiatry.
2006;
67
(10):
1551-60
-
Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder.
Joffe H,
Cohen LS, Suppes T, McLaughlin WL, Lavori P, Adams JM, Hwang CH, Hall JE, Sachs GS.
Biol Psychiatry.
2006;
59
(11):
1078-86
-
Atypical antipsychotics in bipolar depression: potential mechanisms of action.
Yatham LN,
Goldstein JM, Vieta E, Bowden CL, Grunze H, Post RM, Suppes T, Calabrese JR.
J Clin Psychiatry.
2005:
66 Suppl 5
40-8
-
Brief psychiatric rating scale expanded version: How do new items affect factor structure?
Velligan D,
Prihoda T, Dennehy E, Biggs M, Shores-Wilson K, Crismon ML, Rush AJ, Miller A, Suppes T, Trivedi M, Kashner TM, Witte B, Toprac M, Carmody T, Chiles J, Shon S.
Psychiatry Res.
2005;
135
(3):
217-28
-
Challenges in the management of bipolar depression.
Suppes T,
Kelly DI, Perla JM.
J Clin Psychiatry.
2005:
66 Suppl 5
11-6
-
Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients.
Kupka RW,
Luckenbaugh DA, Post RM, Suppes T, Altshuler LL, Keck PE, Frye MA, Denicoff KD, Grunze H, Leverich GS, McElroy SL, Walden J, Nolen WA.
Am J Psychiatry.
2005;
162
(7):
1273-80
-
Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project.
Dennehy EB,
Suppes T, Rush AJ, Miller AL, Trivedi MH, Crismon ML, Carmody TJ, Kashner TM.
Psychol Med.
2005;
35
(12):
1695-706
-
Low doses of clozapine may stabilize treatment-resistant bipolar patients.
Fehr BS,
Ozcan ME, Suppes T.
Eur Arch Psychiatry Clin Neurosci.
2005;
255
(1):
10-4
-
Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon.
Suppes T,
Mintz J, McElroy SL, Altshuler LL, Kupka RW, Frye MA, Keck PE, Nolen WA, Leverich GS, Grunze H, Rush AJ, Post RM.
Arch Gen Psychiatry.
2005;
62
(10):
1089-96
-
Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.
McElroy SL,
Suppes T, Keck PE, Black D, Frye MA, Altshuler LL, Nolen WA, Kupka RW, Leverich GS, Walden J, Grunze H, Post RM.
J Clin Psychiatry.
2005;
66
(5):
617-24
-
Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder.
Post RM,
Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Leverich GS, Kupka R, Nolen WA, Luckenbaugh DA, Walden J, Grunze H.
J Clin Psychiatry.
2005;
66
(3):
370-4
-
Quality of care measures for the treatment of bipolar disorder.
Duffy FF,
Narrow W, West JC, Fochtmann LJ, Kahn DA, Suppes T, Oldham JM, McIntyre JS, Manderscheid RW, Sirovatka P, Regier D.
Psychiatr Q.
2005;
76
(3):
213-30
-
Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
Suppes T,
Brown E, Schuh LM, Baker RW, Tohen M.
J Affect Disord.
2005;
89
(1-3):
69-77
-
Reproductive function and risk for PCOS in women treated for bipolar disorder.
Rasgon NL,
Altshuler LL, Fairbanks L, Elman S, Bitran J, Labarca R, Saad M, Kupka R, Nolen WA, Frye MA, Suppes T, McElroy SL, Keck PE, Leverich G, Grunze H, Walden J, Post R, Mintz J.
Bipolar Disord.
2005;
7
(3):
246-59
-
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.
Suppes T,
Dennehy EB, Hirschfeld RM, Altshuler LL, Bowden CL, Calabrese JR, Crismon ML, Ketter TA, Sachs GS, Swann AC.
J Clin Psychiatry.
2005;
66
(7):
870-86
-
The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence.
Golden RN,
Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, Wisner KL, Nemeroff CB.
Am J Psychiatry.
2005;
162
(4):
656-62
-
Development of a computerized assessment of clinician adherence to a treatment guideline for patients with bipolar disorder.
Dennehy EB,
Suppes T, John Rush A, Lynn Crismon M, Witte B, Webster J.
J Psychiatr Res.
2004 May-Jun;
38
(3):
285-94
-
A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
McElroy SL,
Zarate CA, Cookson J, Suppes T, Huffman RF, Greene P, Ascher J.
J Clin Psychiatry.
2004;
65
(2):
204-10
-
A cautionary note when using zonisamide in youths: a case report of association with toxic epidermal necrolysis.
Majeres KD,
Suppes T.
J Clin Psychiatry.
2004;
65
(12):
1720
-
Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation.
Carlson PJ,
Merlock MC, Suppes T.
Bipolar Disord.
2004;
6
(5):
416-20
-
Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.
Trivedi MH,
Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Key T, Biggs MM, Shores-Wilson K, Witte B, Suppes T, Miller AL, Altshuler KZ, Shon SP.
Arch Gen Psychiatry.
2004;
61
(7):
669-80
-
Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.
Nolen WA,
Luckenbaugh DA, Altshuler LL, Suppes T, McElroy SL, Frye MA, Kupka RW, Keck PE, Leverich GS, Post RM.
Am J Psychiatry.
2004;
161
(8):
1447-54
-
Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder.
Dennehy EB,
Suppes T, Crismon ML, Toprac M, Carmody TJ, Rush AJ.
Psychiatry Res.
2004;
127
(1-2):
137-45
-
Effects of clozapine on sleep in bipolar and schizoaffective disorders.
Armitage R,
Cole D, Suppes T, Ozcan ME.
Prog Neuropsychopharmacol Biol Psychiatry.
2004;
28
(7):
1065-70
-
Management of bipolar disorder during pregnancy and the postpartum period.
Yonkers KA,
Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L.
Am J Psychiatry.
2004;
161
(4):
608-20
-
Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.
Sachs G,
Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, Sweitzer DE.
Bipolar Disord.
2004;
6
(3):
213-23
-
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
Tohen M,
Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, Sachs GS, Kupfer DJ, Ghaemi SN, Feldman PD, Risser RC, Evans AR, Calabrese JR.
Br J Psychiatry.
2004:
184
337-45
-
Response to clozapine of rapid cycling versus non-cycling patients with a history of mania.
Suppes T,
Ozcan ME, Carmody T.
Bipolar Disord.
2004;
6
(4):
329-32
-
Self-reported participation in nonpharmacologic treatments for bipolar disorder.
Dennehy EB,
Gonzalez R, Suppes T.
J Clin Psychiatry.
2004;
65
(2):
278
-
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation.
Trivedi MH,
Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM.
Psychol Med.
2004;
34
(1):
73-82
-
The Texas medication algorithm project: clinical results for schizophrenia.
Miller AL,
Crismon ML, Rush AJ, Chiles J, Kashner TM, Toprac M, Carmody T, Biggs M, Shores-Wilson K, Chiles J, Witte B, Bow-Thomas C, Velligan DI, Trivedi M, Suppes T, Shon S.
Schizophr Bull.
2004;
30
(3):
627-47
-
Treatment of bipolar mania with atypical antipsychotics.
Chengappa KN,
Suppes T, Berk M.
Expert Rev Neurother.
2004;
4
(6 Suppl 2):
S17-25
-
Treatment of rapid-cycling bipolar disorder.
Post RM,
Chang KD, Suppes T.
CNS Spectr.
2004;
9
(2):
1-11
-
Use of quetiapine in bipolar disorder: a case series with prospective evaluation.
Suppes T,
McElroy SL, Keck PE, Altshuler L, Frye MA, Grunze H, Leverich GS, Nolen WA, Chisholm K, Dennehy EB, Post RM.
Int Clin Psychopharmacol.
2004;
19
(3):
173-4
-
Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness.
Keck PE,
McElroy SL, Havens JR, Altshuler LL, Nolen WA, Frye MA, Suppes T, Denicoff KD, Kupka R, Leverich GS, Rush AJ, Post RM.
Compr Psychiatry.
2003 Jul-Aug;
44
(4):
263-9
-
A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.
Post RM,
Leverich GS, Nolen WA, Kupka RW, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck P, Grunze H, Walden J.
Bipolar Disord.
2003;
5
(6):
396-406
-
An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).
Post RM,
Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE, McElroy SL, Kupka R, Nolen WA, Grunze H, Walden J.
Bipolar Disord.
2003;
5
(5):
310-9
-
Catching up on health outcomes: the Texas Medication Algorithm Project.
Kashner TM,
Carmody TJ, Suppes T, Rush AJ, Crismon ML, Miller AL, Toprac M, Trivedi M.
Health Serv Res.
2003;
38
(1 Pt 1):
311-31
-
Clinician ratings vs. global ratings of symptom severity: a comparison of symptom measures in the bipolar disorder module, phase II, Texas Medication Algorithm Project.
Brown ES,
Rush AJ, Biggs MM, Shores-Wilson K, Carmody TJ, Suppes T.
Psychiatry Res.
2003;
117
(2):
167-75
-
Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network.
Leverich GS,
Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Denicoff KD, Obrocea G, Nolen WA, Kupka R, Walden J, Grunze H, Perez S, Luckenbaugh DA, Post RM.
J Clin Psychiatry.
2003;
64
(5):
506-15
-
Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder.
Frye MA,
Altshuler LL, McElroy SL, Suppes T, Keck PE, Denicoff K, Nolen WA, Kupka R, Leverich GS, Pollio C, Grunze H, Walden J, Post RM.
Am J Psychiatry.
2003;
160
(5):
883-9
-
High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder.
Breunis MN,
Kupka RW, Nolen WA, Suppes T, Denicoff KD, Leverich GS, Post RM, Drexhage HA.
Biol Psychiatry.
2003;
53
(2):
157-65
-
How rare is bipolar disorder not otherwise specified?
Ozcan ME,
Shiekh M, Suppes T.
Bipolar Disord.
2003;
5
(3):
226-7
-
Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.
Altshuler L,
Suppes T, Black D, Nolen WA, Keck PE, Frye MA, McElroy S, Kupka R, Grunze H, Walden J, Leverich G, Denicoff K, Luckenbaugh D, Post R.
Am J Psychiatry.
2003;
160
(7):
1252-62
-
Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method.
Post RM,
Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Rush AJ, Keck PE, McElroy SL, Luckenbaugh DA, Pollio C, Kupka R, Nolen WA.
J Clin Psychiatry.
2003;
64
(6):
680-90; quiz 738-9
-
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
Tohen M,
Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh LM, Risser RC, Brown E, Baker RW.
Am J Psychiatry.
2003;
160
(7):
1263-71
-
Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania.
Suppes T,
Rush AJ, Dennehy EB, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Brown ES, Biggs MM, Shores-Wilson K, Witte BP, Trivedi MH, Miller AL, Altshuler KZ, Shon SP.
J Clin Psychiatry.
2003;
64
(4):
370-82
-
Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.
Rush AJ,
Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Trivedi MH, Suppes T, Miller AL, Biggs MM, Shores-Wilson K, Witte BP, Shon SP, Rago WV, Altshuler KZ.
J Clin Psychiatry.
2003;
64
(4):
357-69
-
The efficacy of olanzapine monotherapy for acute hypomania or mania in an outpatient setting.
Dennehy EB,
Doyle K, Suppes T.
Int Clin Psychopharmacol.
2003;
18
(3):
143-5
-
Assessment of beliefs in the effectiveness of acupuncture for treatment of psychiatric symptoms.
Dennehy EB,
Webb A, Suppes T.
J Altern Complement Med.
2002;
8
(4):
421-5
-
Correlates of overweight and obesity in 644 patients with bipolar disorder.
McElroy SL,
Frye MA, Suppes T, Dhavale D, Keck PE, Leverich GS, Altshuler L, Denicoff KD, Nolen WA, Kupka R, Grunze H, Walden J, Post RM.
J Clin Psychiatry.
2002;
63
(3):
207-13
-
Developing novel treatments for mood disorders: accelerating discovery.
Tamminga CA,
Nemeroff CB, Blakely RD, Brady L, Carter CS, Davis KL, Dingledine R, Gorman JM, Grigoriadis DE, Henderson DC, B Innis RB, Killen J, Laughren TP, McDonald WM, M Murphy GM, Paul SM, Rudorfer MV, Sausville E, Schatzberg AF, Scolnick EM, Suppes T.
Biol Psychiatry.
2002;
52
(6):
589-609
-
Early physical and sexual abuse associated with an adverse course of bipolar illness.
Leverich GS,
McElroy SL, Suppes T, Keck PE, Denicoff KD, Nolen WA, Altshuler LL, Rush AJ, Kupka R, Frye MA, Autio KA, Post RM.
Biol Psychiatry.
2002;
51
(4):
288-97
-
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Tohen M,
Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.
Arch Gen Psychiatry.
2002;
59
(1):
62-9
-
Evidence-based long-term treatment of bipolar II disorder.
Suppes T,
Dennehy EB.
J Clin Psychiatry.
2002:
63 Suppl 10
29-33
-
High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure.
Kupka RW,
Nolen WA, Post RM, McElroy SL, Altshuler LL, Denicoff KD, Frye MA, Keck PE, Leverich GS, Rush AJ, Suppes T, Pollio C, Drexhage HA.
Biol Psychiatry.
2002;
51
(4):
305-11
-
Mood changes during prednisone bursts in outpatients with asthma.
Brown ES,
Suppes T, Khan DA, Carmody TJ.
J Clin Psychopharmacol.
2002;
22
(1):
55-61
-
Olanzapine versus divalproex in the treatment of acute mania.
Tohen M,
Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA, Milton DR, Risser R, Gilmore JA, Breier A, Tollefson GA.
Am J Psychiatry.
2002;
159
(6):
1011-7
-
Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.
Calabrese JR,
Sullivan JR, Bowden CL, Suppes T, Goldberg JF, Sachs GS, Shelton MD, Goodwin FK, Frye MA, Kusumakar V.
J Clin Psychiatry.
2002;
63
(11):
1012-9
-
Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000.
Suppes T,
Dennehy EB, Swann AC, Bowden CL, Calabrese JR, Hirschfeld RM, Keck PE, Sachs GS, Crismon ML, Toprac MG, Shon SP.
J Clin Psychiatry.
2002;
63
(4):
288-99
-
Review of the use of topiramate for treatment of bipolar disorders.
Suppes T,
J Clin Psychopharmacol.
2002;
22
(6):
599-609
-
Tiagabine in treatment refractory bipolar disorder: a clinical case series.
Suppes T,
Chisholm KA, Dhavale D, Frye MA, Altshuler LL, McElroy SL, Keck PE, Nolen WA, Kupka R, Denicoff KD, Leverich GS, Rush AJ, Post RM.
Bipolar Disord.
2002;
4
(5):
283-9
-
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.
McElroy SL,
Altshuler LL, Suppes T, Keck PE, Frye MA, Denicoff KD, Nolen WA, Kupka RW, Leverich GS, Rochussen JR, Rush AJ, Post RM.
Am J Psychiatry.
2001;
158
(3):
420-6
-
Bipolar rapid cycling: focus on depression as its hallmark.
Calabrese JR,
Shelton MD, Bowden CL, Rapport DJ, Suppes T, Shirley ER, Kimmel SE, Caban SJ.
J Clin Psychiatry.
2001:
62 Suppl 14
34-41
-
Drug abuse and bipolar disorder: comorbidity or misdiagnosis?
Sherwood Brown E,
Suppes T, Adinoff B, Rajan Thomas N.
J Affect Disord.
2001;
65
(2):
105-15
-
Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia.
Glick ID,
Suppes T, DeBattista C, Hu RJ, Marder S.
Ann Intern Med.
2001;
134
(1):
47-60
-
Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers.
Post RM,
Altshuler LL, Frye MA, Suppes T, Rush AJ, Keck PE, McElroy SL, Denicoff KD, Leverich GS, Kupka R, Nolen WA.
Bipolar Disord.
2001;
3
(5):
259-65
-
Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder.
Suppes T,
Swann AC, Dennehy EB, Habermacher ED, Mason M, Crismon ML, Toprac MG, Rush AJ, Shon SP, Altshuler KZ.
J Clin Psychiatry.
2001;
62
(6):
439-47
-
The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatments.
Kupka RW,
Nolen WA, Altshuler LL, Denicoff KD, Frye MA, Leverich GS, Keck PE, McElroy SL, Rush AJ, Suppes T, Post RM.
Br J Psychiatry Suppl.
2001:
41
s177-83
-
The Stanley Foundation Bipolar Network. I. Rationale and methods.
Post RM,
Nolen WA, Kupka RW, Denicoff KD, Leverich GS, Keck PE, McElroy SL, Rush AJ, Suppes T, Altshuler LL, Frye MA, Grunze H, Walden J.
Br J Psychiatry Suppl.
2001:
41
s169-76
-
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology.
Leverich GS,
Nolen WA, Rush AJ, McElroy SL, Keck PE, Denicoff KD, Suppes T, Altshuler LL, Kupka R, Kramlinger KG, Post RM.
J Affect Disord.
2001;
67
(1-3):
33-44
-
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients.
Suppes T,
Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, McElroy SL, Rush AJ, Kupka R, Frye MA, Bickel M, Post RM.
J Affect Disord.
2001;
67
(1-3):
45-59
-
Comparison of the internal state scale to clinician-administered scales in asthma patients receiving corticosteroid therapy.
Brown ES,
Bauer MS, Suppes T, Khan DA, Carmody T.
Gen Hosp Psychiatry.
2000 May-Jun;
22
(3):
180-3
-
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.
Calabrese JR,
Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V, Ascher JA, Earl NL, Greene PL, Monaghan ET.
J Clin Psychiatry.
2000;
61
(11):
841-50
-
A review of randomized, controlled clinical trials in acute mania.
Keck PE,
Mendlwicz J, Calabrese JR, Fawcett J, Suppes T, Vestergaard PA, Carbonell C.
J Affect Disord.
2000:
59 Suppl 1
S31-S37
-
Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
Kowatch RA,
Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, Emslie GJ, Weinberg WA, Rush AJ.
J Am Acad Child Adolesc Psychiatry.
2000;
39
(6):
713-20
-
Efficacy of divalproex therapy for schizoaffective disorder.
Bogan AM,
Brown ES, Suppes T.
J Clin Psychopharmacol.
2000;
20
(5):
520-2
-
Forum. What are the mental health complications of steroid therapy?
Brown ES,
Suppes T.
Harv Ment Health Lett.
2000;
16
(8):
8
-
Methodological issues in developing new acute treatments for patients with bipolar illness.
Rush AJ,
Post RM, Nolen WA, Keck PE, Suppes T, Altshuler L, McElroy SL.
Biol Psychiatry.
2000;
48
(6):
615-24
-
Open-label adjunctive topiramate in the treatment of bipolar disorders.
McElroy SL,
Suppes T, Keck PE, Frye MA, Denicoff KD, Altshuler LL, Brown ES, Nolen WA, Kupka RW, Rochussen J, Leverich GS, Post RM.
Biol Psychiatry.
2000;
47
(12):
1025-33
-
Switching outpatients between atypical antipsychotics.
Bogan AM,
Shellhorn E, Brown ES, McDanald C, Suppes T.
Prog Neuropsychopharmacol Biol Psychiatry.
2000;
24
(2):
351-5
-
The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis.
Tohen M,
Strakowski SM, Zarate C, Hennen J, Stoll AL, Suppes T, Faedda GL, Cohen BM, Gebre-Medhin P, Baldessarini RJ.
Biol Psychiatry.
2000;
48
(6):
467-76
-
The longitudinal course of bipolar disorder.
Suppes T,
Dennehy EB, Gibbons EW.
J Clin Psychiatry.
2000:
61 Suppl 9
23-30
-
Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features.
Tohen M,
Hennen J, Zarate CM, Baldessarini RJ, Strakowski SM, Stoll AL, Faedda GL, Suppes T, Gebre-Medhin P, Cohen BM.
Am J Psychiatry.
2000;
157
(2):
220-8
-
Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness.
Denicoff KD,
Leverich GS, Nolen WA, Rush AJ, McElroy SL, Keck PE, Suppes T, Altshuler LL, Kupka R, Frye MA, Hatef J, Brotman MA, Post RM.
Psychol Med.
2000;
30
(6):
1391-7
-
Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
Suppes T,
Webb A, Paul B, Carmody T, Kraemer H, Rush AJ.
Am J Psychiatry.
1999;
156
(8):
1164-9
-
Clozapine associated with decreased suicidality in bipolar disorder: a case report.
Vangala VR,
Brown ES, Suppes T.
Bipolar Disord.
1999;
1
(2):
123-4
-
Gabapentin in the acute treatment of refractory bipolar disorder.
Altshuler LL,
Keck PE, McElroy SL, Suppes T, Brown ES, Denicoff K, Frye M, Gitlin M, Hwang S, Goodman R, Leverich G, Nolen W, Kupka R, Post R.
Bipolar Disord.
1999;
1
(1):
61-5
-
Lamotrigine for the treatment of bipolar disorder: a clinical case series.
Suppes T,
Brown ES, McElroy SL, Keck PE, Nolen W, Kupka R, Frye M, Denicoff KD, Altshuler L, Leverich GS, Post RM.
J Affect Disord.
1999;
53
(1):
95-8
-
Lamotrigine in the treatment of bipolar depression.
Bowden CL,
Mitchell P, Suppes T.
Eur Neuropsychopharmacol.
1999:
9 Suppl 4
S113-7
-
Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project.
Rush AJ,
Rago WV, Crismon ML, Toprac MG, Shon SP, Suppes T, Miller AL, Trivedi MH, Swann AC, Biggs MM, Shores-Wilson K, Kashner TM, Pigott T, Chiles JA, Gilbert DA, Altshuler KZ.
J Clin Psychiatry.
1999;
60
(5):
284-91
-
Mental health care from the public perspective: the Texas Medication Algorithm Project.
Shon SP,
Crismon ML, Toprac MG, Trivedi M, Miller AL, Suppes T, Rush AJ.
J Clin Psychiatry.
1999:
60 Suppl 3
16-20; discussion 21
-
Treating bipolar illness: focus on treatment algorithms and management of the sleep-wake cycle.
Leibenluft E,
Suppes T.
Am J Psychiatry.
1999;
156
(12):
1976-81
-
Treatment of corticosteroid-induced mood changes with olanzapine.
Brown ES,
Khan DA, Suppes T.
Am J Psychiatry.
1999;
156
(6):
968
-
Mood symptoms during corticosteroid therapy: a review.
Brown ES,
Suppes T.
Harv Rev Psychiatry.
1998 Jan-Feb;
5
(5):
239-46
-
A new algorithm for treating schizophrenia.
Pearsall R,
Glick ID, Pickar D, Suppes T, Tauscher J, Jobson KO.
Psychopharmacol Bull.
1998;
34
(3):
349-53
-
Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania.
Knoll J,
Stegman K, Suppes T.
J Affect Disord.
1998;
49
(3):
229-33
-
Gastrointestinal side-effects after switch to generic valproic acid.
Sherwood Brown E,
Shellhorn E, Suppes T.
Pharmacopsychiatry.
1998;
31
(3):
114
-
Olanzapine in treatment-resistant bipolar disorder.
McElroy SL,
Frye M, Denicoff K, Altshuler L, Nolen W, Kupka R, Suppes T, Keck PE, Leverich GS, Kmetz GF, Post RM.
J Affect Disord.
1998;
49
(2):
119-22
-
Treatment algorithm use to optimize management of symptomatic patients with a history of mania.
Suppes T,
Rush AJ, Kraemer HC, Webb A.
J Clin Psychiatry.
1998;
59
(2):
89-96; quiz 97-8
-
What are the new treatments for bipolar disorder?
Rush AJ,
Suppes T.
Harv Ment Health Lett.
1998;
14
(11):
8
-
Gabapentin for treatment of bipolar and schizoaffective disorders.
Bennett J,
Goldman WT, Suppes T.
J Clin Psychopharmacol.
1997;
17
(2):
141-2
-
Special treatment issues: maintaining and discontinuing psychotropic medications.
Suppes T,
Baldessarini RJ, Motohashi N, Tondo L, Viguera AC.
Mod Probl Pharmacopsychiatry.
1997:
25
235-54
-
The atypical antipsychotic sertindole: a case series.
Lee AM,
Knoll JL, Suppes T.
J Clin Psychiatry.
1997;
58
(9):
410-6; quiz 417-8
-
Capgras'and Fregoli's syndromes in one family.
Brown ES,
Thompson R, Suppes T.
J Clin Psychiatry.
1996;
57
(3):
137-8
-
Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders.
Baldessarini RJ,
Tondo L, Faedda GL, Suppes TR, Floris G, Rudas N.
J Clin Psychiatry.
1996;
57
(10):
441-8
-
Is postictal electrical silence a predictor of response to electroconvulsive therapy?
Suppes T,
Webb A, Carmody T, Gordon E, Gutierrez-Esteinou R, Hudson JI, Pope HG.
J Affect Disord.
1996;
41
(1):
55-8
-
Lithium Withdrawal in Bipolar Disorder: Implications for Clinical Practice and Experimental Therapeutics Research.
Baldessarini RJ,
Suppes T, Tondo L.
Am J Ther.
1996;
3
(7):
492-496
-
Medication optimization during clozapine treatment.
Suppes T,
Rush AJ.
J Clin Psychiatry.
1996;
57
(7):
307-8
-
Pediatric-onset bipolar disorder: a neglected clinical and public health problem.
Faedda GL,
Baldessarini RJ, Suppes T, Tondo L, Becker I, Lipschitz DS.
Harv Rev Psychiatry.
1995 Nov-Dec;
3
(4):
171-95
-
A clinically significant interaction between clozapine and valproate.
Costello LE,
Suppes T.
J Clin Psychopharmacol.
1995;
15
(2):
139-41
-
Algorithms for the treatment of bipolar manic-depressive illness.
Suppes T,
Calabrese JR, Mitchell PB, Pazzaglia PJ, Potter WZ, Zarin DA.
Psychopharmacol Bull.
1995;
31
(3):
469-74
-
Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases.
Suppes T,
Phillips KA, Judd CR.
Biol Psychiatry.
1994;
36
(5):
338-40
-
Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders.
Stoll AL,
Banov M, Kolbrener M, Mayer PV, Tohen M, Strakowski SM, Castillo J, Suppes T, Cohen BM.
J Clin Psychopharmacol.
1994;
14
(5):
311-3
-
Discontinuation of maintenance treatment in bipolar disorder: risks and implications.
Suppes T,
Baldessarini RJ, Faedda GL, Tondo L, Tohen M.
Harv Rev Psychiatry.
1993 Sep-Oct;
1
(3):
131-44
-
Combined Clozapine and Electroconvulsive Therapy.
Frankenburg FR,
Suppes T, McLean PE.
Convuls Ther.
1993;
9
(3):
176-180
-
Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders.
Faedda GL,
Tondo L, Baldessarini RJ, Suppes T, Tohen M.
Arch Gen Psychiatry.
1993;
50
(6):
448-55
-
Stereotypical changes in the pattern and duration of long-term potentiation expressed at postnatal days 11 and 15 in the rat hippocampus.
Jackson PS,
Suppes T, Harris KM.
J Neurophysiol.
1993;
70
(4):
1412-9
-
Clozapine in the treatment of dysphoric mania.
Suppes T,
McElroy SL, Gilbert J, Dessain EC, Cole JO.
Biol Psychiatry.
1992;
32
(3):
270-80
-
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
Suppes T,
Baldessarini RJ, Faedda GL, Tohen M.
Arch Gen Psychiatry.
1991;
48
(12):
1082-8
-
Cellular and synaptic physiology and epileptogenesis of developing rat neocortical neurons in vitro.
Kriegstein AR,
Suppes T, Prince DA.
Brain Res.
1987;
431
(2):
161-71
-
Sensitivity of neuronal dopamine response in the substantia nigra and ventral tegmentum to clozapine, metoclopramide and SCH 23390.
Suppes T,
Pinnock RD.
Neuropharmacology.
1987;
26
(4):
331-7
-
The influence of dopamine on epileptiform burst activity in hippocampal pyramidal neurons.
Suppes T,
Kriegstein AR, Prince DA.
Brain Res.
1985;
326
(2):
273-80
-
A late slow depolarization unmasked in the presence of tetraethylammonium in neonatal rat sympathetic neurons in vitro.
Suppes T,
Brain Res.
1984;
293
(2):
269-78
-
Cholinergic enhancement of penicillin-induced epileptiform discharges in pyramidal neurons of the guinea pig hippocampus.
Kriegstein AR,
Suppes T, Prince DA.
Brain Res.
1983;
266
(1):
137-42
Navigation for This Section: Stanford Hospital & Clinics
Additional Links: Hospital Services
FIND A PHYSICIAN
Help